Cefpodoxime proxetil
Caitlin Soto, PharmD, BCIDP, Edina Avdic, Pharm.D., BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Approved for the following mild-moderate bacterial infections:
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Prophylaxis in neutropenic fever in patients who are intolerant of fluoroquinolones
- Oral alternative therapy for pyelonephritis without bacteremia in patients who are resistant to fluoroquinolones or trimethoprim/sulfamethoxazole.
- IDSA 2025 complicated UTI Guideline recommends:
- Complicated UTI (including acute pyelonephritis), avoid antibiotics to which the patient has had a resistant pathogen isolated from the urine previously
- For pylenephritis, including sepsis/shock, once clinically improved, can have an early transition from parenteral to oral therapy if such an.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.